EXHIBIT 31.1

                            CERTIFICATION OF CHAIRMAN
                 PURSUANT TO THE SECURITIES EXCHANGE ACT OF 1934
                             RULES 13A-14 AND 15D-14
                             AS ADOPTED PURSUANT TO
                 SECTION 302 OF THE SARBANNES-OXLEY ACT OF 2002


In connection with the Annual; Report of PracticeXpert, Inc. (the "Company") on
Form 10-KSB for the period ending December 31, 2005 as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, Jonathan Doctor,
Chairman of the Company, certify, pursuant to Rules 13a-14 and 15d-14 of the
Securities Exchange Act of 1934, as adopted pursuant to ss.302 of the
Sarbanes-Oxley Act of 2002, that:

      (1)   I have reviewed the Report;

      (2)   Based on my knowledge, the Report does not contain any untrue
            statement of material fact or omit a material fact necessary in
            order to make the statements made, in light of the circumstances
            under which such statements were made, not misleading,

      (3)   Based on my knowledge, the financial statements, and other financial
            information included in the Report, fairly present in all material
            respects the financial condition and results of operations of the
            Company, as of, and for, the periods presented in the Report,

      (4)   I and the other certifying officers of the Company:

            a.  are responsible for establishing and maintaining disclosure
                controls and procedures for the Company;
            b.  have designed such disclosure controls and procedures to ensure
                that material information is made known to us, particularly
                during the period in which the Report is being prepared;
            c.  have evaluated the effectiveness of the Company's disclosure
                controls and procedures within 90 days of the date of the
                Report; and
            d.  have presented in the Report our conclusions about the
                effectiveness of the disclosure controls and procedures based on
                the required evaluation.

<PAGE>

      (5)   I and the other certifying officers have disclosed to the Company's
            auditors and to the audit committee of the board of directors (or
            persons fulfilling the equivalent function):

            a.  all significant deficiencies in the design of operation of
                internal controls (a pre-existing term relating to internal
                controls regarding financial reporting) which could adversely
                affect the Company's ability to record process, summarize and
                report financial data and have identified for the Company's
                auditors any material weaknesses in internal controls; and
            b.  any fraud, whether or not material, that involves management or
                other employees who have a significant role in the Company's
                internal controls.

      (6)   I and the other certifying officers have indicated in the Report
            whether or not there were significant changes in internal controls
            or in other factors that could significantly affect internal
            controls subsequent to the date of their evaluation, including any
            corrective actions with regard to significant deficiencies and
            material weaknesses.


                                                 /s/ Jonathan Doctor
                                                 -------------------------
                                                 Jonathan Doctor,
                                                 Chairman of the Board

                                                 April 12, 2006